About Maaguzi
Maaguzi is a Healthcare company based in Indianapolis (United States) founded in 2005, and was acquired by Phase Forward in July 2009. Patient reported outcomes are collected through web and mobile platforms. Maaguzi has raised $375 thousand across 1 funding round from investors including Phase Forward. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Maaguzi LLC. Its competitors include Medrio, L7 Informatics and Clinical Research IO; 3 of its 3 listed competitors have raised funding.
Company details
Maaguzi was founded in 2005 in Indianapolis, United States, focusing on the life sciences sector. Web-based and mobile tools for Patient Reported Outcomes (PRO) and Site Reported Data Collection are developed and deployed. The OutcomeLogix platform is applied in therapeutic fields including Mens Health, Endocrinology, Respiratory, and CNS conditions like Depression, Anxiety, Schizophrenia, and ADHD. Investigator data and patient inputs are unified within a single database interface.
- Headquarters Indianapolis, United States
- Stage Acquired
- SectorsHealthcare
- Website maaguzi.com
- Social LinkedIn X
- Acquired by Phase Forward (Jul 2009)
- Legal Name Maaguzi Llc
- Total Equity Funding$375K (USD)
in 1 rounds
- Latest Funding Round$375K (USD), Seed
Jul 2009
- Investors
- Acquired byPhase Forward
(Jul 2009)
Funding Insights of Maaguzi
Maaguzi has successfully raised a total of $375K through 1 strategic funding round. The most recent funding activity was a Seed round of $375 thousand completed in July 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $375,000
- Total Rounds 1
- Last Round Seed — $375,000
- First Round $375,000
(Jul 2009)
All 1 funding rounds of Maaguzi with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2009 | $375,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Maaguzi
Maaguzi has secured backing from 1 investor. Prominent investors backing the company include Phase Forward.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Data collection and data management solutions for clinical trials and drug safety. | 1997 | phaseforward.com | Waltham, United States |
Investor details for Maaguzi
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Maaguzi
3 dated milestones of Maaguzi across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Maaguzi is founded.
- Funding First funding round of $375K.
- Exit Acquired by Phase Forward.
Competitors of Maaguzi
Maaguzi has 3 listed competitors in our database, 3 of them funded. They include Medrio, L7 Informatics and Clinical Research IO.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| medrio.com | 2005 | San Francisco, United States | $32.03M | 120 | Cloud-based eClinical software for clinical trials is provided. | |
| l7informatics.com | 2012 | Austin, United States | $54.97M | 126 | Clinical trial workflow management software is provided for laboratories. | |
| clinicalresearch.io | 2015 | Boston, United States | $16.7M | 16 | Clinical trial management software is provided for research sites. |
Detailed competitors of Maaguzi
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Maaguzi (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Maaguzi
Maaguzi was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Maaguzi is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
Maaguzi is a funded company, having raised a total of $375K across 1 funding round to date. The company's 1st funding round was a Seed of $375K, raised on Jul 2009.
Maaguzi was founded in 2005 in Indianapolis, United States, focusing on the life sciences sector. Web-based and mobile tools for Patient Reported Outcomes (PRO) and Site Reported Data Collection are developed and deployed. The OutcomeLogix platform is applied in therapeutic fields including Mens Health, Endocrinology, Respiratory, and CNS conditions like Depression, Anxiety, Schizophrenia, and ADHD. Investigator data and patient inputs are unified within a single database interface.
Maaguzi's top competitors include L7 Informatics, Medrio and Clinical Research IO.
Maaguzi has 1 investor. Key investors include Phase Forward.
Maaguzi operates through Maaguzi Llc.
Yes. Maaguzi was acquired by Phase Forward in July 2009.